Cargando…

COVID-19 pneumonia, immunosuppression, and cytomegalovirus activation: A perspective

Detalles Bibliográficos
Autor principal:	Ghosh, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253334/ https://www.ncbi.nlm.nih.gov/pubmed/33942769 http://dx.doi.org/10.4103/jpgm.JPGM_55_21

Ejemplares similares

Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection
por: Meena, Priti, et al.
Publicado: (2022)

Cytomegalovirus pneumonia in an immunosuppressed sarcoidosis patient; a rare case of cytomegalovirus infection in a sarcoidosis patient
por: Mozdourian, Mahnaz, et al.
Publicado: (2021)

Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments
por: Maillet, François, et al.
Publicado: (2021)

Does reactivation of cytomegalovirus contribute to severe COVID-19 disease?
por: Söderberg-Nauclér, Cecilia
Publicado: (2021)

Immunosuppressants: COVID-19 and cytomegalovirus reactivation: 2 case reports
Publicado: (2021)

Restimulating Interest in Cytomegalovirus as a Cofactor for HIV Infection
por: Emery, Vincent C.
Publicado: (2015)

The paradox of immunosuppressants and COVID-19
por: Cheng, Guang-Shing, et al.
Publicado: (2022)

Immunosuppressants: COVID-19 infection and cytomegalovirus infection: 5 case reports
Publicado: (2021)

The relationship of immunosuppression to cytomegalovirus infection.
por: Dowling, J. N., et al.
Publicado: (1976)

Acute myeloid leukemia with 3q26 abnormality: An editorial perspective
por: Ghosh, K
Publicado: (2018)

Tyrosine kinase domain mutations in chronic myelogenous leukemia patients: Indian perspective
por: Ghosh, K
Publicado: (2022)

Novel coronavirus (COVID-19) pneumonia: Portable chest X-ray or computed tomography? An Italian perspective
por: Mazzei, Maria Antonietta, et al.
Publicado: (2021)

Immunosuppressants: COVID-19, Cytomegalovirus reactivation and Pseudomonas infection: 4 case reports
Publicado: (2022)

Immunosuppression for COVID-19: repurposing medicines in a pandemic
por: Shivakumar, Senthuran, et al.
Publicado: (2020)

Immunosuppressive and Proinflammatory Activities of the VacA Toxin of Helicobacter pylori
por: Montecucco, Cesare, et al.
Publicado: (2003)

Immunosuppressants: COVID-19 pneumonia: case report
Publicado: (2021)

A novel immunosuppression-based classification of liver tumors opens new perspectives for adapted therapeutic strategies
por: Bévant, Kevin, et al.
Publicado: (2020)

Cancer immunotherapy by immunosuppression
por: Prehn, Richmond T, et al.
Publicado: (2010)

To immunosuppress: whom, when and how? That is the question with COVID-19
por: Winthrop, Kevin L, et al.
Publicado: (2020)

COVID 19 and diabetes: An endocrinologist's perspective
por: Behera, Kishore K., et al.
Publicado: (2020)

Tailoring management and immunosuppression regimen in kidney transplant recipients with COVID-19 infection: lessons from Singapore
por: Chang, Zi Yun, et al.
Publicado: (2021)

Pharyngeal Antisepsis to Reduce COVID-19 Pneumonia
por: Davidson, Bruce L., et al.
Publicado: (2021)

Covid-19 pneumonia and pulmonary vascular disease: A UK Centre perspective
por: John Wort, S., et al.
Publicado: (2020)

Cytomegalovirus Pneumonia in Patients with Rheumatic Diseases After Immunosuppressive Therapy: A Single Center Study in China
por: Xue, Yu, et al.
Publicado: (2016)

Mucormycosis and Cytomegalovirus Co-infection in Renal Transplant Recipients
por: Gupta, K. L.
Publicado: (2017)

Immunosuppressants: COVID-19 and COVID-19-pneumonia: 19 case reports
Publicado: (2021)

Cytomegalovirus: Why Viral Dynamics Matter
por: Mueller, Nicolas J.
Publicado: (2015)

Prevention of Maternal–Fetal Transmission of Cytomegalovirus
por: Adler, Stuart P.
Publicado: (2015)

Porcine cytomegalovirus: A very unwelcome stowaway
por: Mueller, Nicolas J.
Publicado: (2022)

Testing the efficacy of tocilizumab in patients with COVID-19 pneumonia
por: Agirbasli, Mehmet, et al.
Publicado: (2021)

COVID-19: An Alert to Ventilator-Associated Bacterial Pneumonia
por: Póvoa, Helvécio Cardoso Corrêa, et al.
Publicado: (2020)

Immunosuppressants: COVID-19 pneumonia: 6 case reports
Publicado: (2021)

Immunosuppressants: COVID-19 pneumonia: 10 case reports
Publicado: (2020)

Immunosuppressants: COVID-19-pneumonia: 2 case reports
Publicado: (2020)

Immunosuppressant: COVID-19 pneumonia: 2 case reports
Publicado: (2020)

Anticoagulants and Immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS
por: Turi, S, et al.
Publicado: (2020)

Evidence-Based Health Policies and Its Discontents – Comparative Global and Indian Perspectives with a Focus on the COVID-19 Pandemic
por: Basu, Saurav
Publicado: (2021)

Commentary: A case of endogenous candida endophthalmitis with incidental cytomegalovirus infection and optic neuropathy in a patient recovered from severe COVID-19
por: Shah, Vedang
Publicado: (2022)

Report from the second cytomegalovirus and immunosenescence workshop
por: Wills, Mark, et al.
Publicado: (2011)

The latent cytomegalovirus decreases telomere length by microcompetition
por: Polansky, Hanan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_02acve3c95qicha5u40bhu3glo